Academic Journal
Q1Liver Transplantation
About Liver Transplantation
About Liver Transplantation
Liver Transplantation is a peer-reviewed scholarly journal published by Lippincott Williams and Wilkins (United States). It focuses on Q1. Publication coverage spans 2000-2026.
Key indicators: ISSN 1527-6465, 1527-6473; H-index 177.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (177): Exceptionally high — 177 articles have each been cited at least 177 times. This indicates deep, sustained influence in the field.
Publishing in Liver Transplantation
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Liver Transplantation?
1527-6465, 1527-6473.
Who publishes Liver Transplantation?
Lippincott Williams and Wilkins.
What are Liver Transplantation's metrics?
H-index 177.
Where do I submit to Liver Transplantation?
Via the official website.
Is Liver Transplantation peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Organ Transplantation Techniques and Outcomes; Liver Disease and Transplantation; Liver Disease Diagnosis and Treatment; Renal Transplantation Outcomes and Treatments; Organ Donation and Transplantation; Hepatitis C virus research.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
2,150.00 USD; 2,000.00 EUR; 1,550.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Robotic recipient surgery in living donor liver transplantation: A single-center consecutive case series
Su Young Hong, YoungRok Choi, Kwang-Woong Lee, Gayoung Kim et al.
2026-10-07 · DOI: 10.1097/lvt.0000000000001016Mitigating infection risk in liver transplant recipients – the swan song for synbiotics?
Audrey Han Ngoc Le-Mahajan
2026-10-07 · DOI: 10.1097/lvt.0000000000001005External validation of the SALT-M score in living donor liver transplantation for acute-on-chronic liver failure
Bandar M. Aljudaibi, Dimitri A. Raptis, Lama Alshehri, Kris Ann H. Marquez et al.
2026-10-07 · DOI: 10.1097/lvt.0000000000001017Vasoconstrictor therapy for HRS-AKI in patients listed for liver transplantation: Translating evidence to the pretransplant setting
Nazli Begum Ozturk, Konstantinos Ouranos, Rohan Garg, Ahila Manivannan et al.
2026-10-02 · DOI: 10.1097/lvt.0000000000001012Reply: Prophylactic Tranexamic Acid in Liver Transplantation—Looking Beyond the Primary Endpoint
Eduarda S. Martinelli, André P. Schmidt, Luiz Marcelo S. Malbouisson
2026-10-01 · DOI: 10.1097/lvt.0000000000001014Letter to the Editor: Prophylactic tranexamic acid in liver transplantation—looking beyond the primary endpoint
Diana Elizabeth Díaz Arizmendi, Rafael Paulino Leal Villalpando, Mariana Rebeca Baéz Lima
2026-09-30 · DOI: 10.1097/lvt.0000000000001013Reply: Reconsidering the temporal dynamics of sarcopenia in MELD-based allocation bias—A Clinical Perspective
Shivangi Gupta, Angus W. Jeffrey, Zhengyi Wang, Leon A. Adams et al.
2026-09-29 · DOI: 10.1097/lvt.0000000000001008Definitive surgical outcomes in children with advanced hepatoblastoma (PRETEXT III–IV): A retrospective single-center canadian experience
Sagar Mehta, Blayne Amir Sayed, Furqan Shaikh, Fernanda Takamatsu et al.
2026-09-29 · DOI: 10.1097/lvt.0000000000001006From area-level deprivation to individual social risk: Rethinking social risk assessment across the hepatocellular carcinoma care continuum
Elizabeth S. Aby, Nneka N. Ufere
2026-09-29 · DOI: 10.1097/lvt.0000000000001010The clot thickens: Portal vein thrombosis as a barometer of vascular disease in cirrhosis
Amanda Pirola, Justin Boike
2026-09-29 · DOI: 10.1097/lvt.0000000000001007Letter to the Editor: outcome definition, class enumeration, and transportability of machine learning–derived ascites phenotypes
Imen Ben Ismail
2026-09-29 · DOI: 10.1097/lvt.0000000000001009Liver transplantation from SARS-CoV-2-positive deceased donors: Thrombotic risk, graft implications, and the impact of perioperative management
Asim Abdulhamid, Charles Rosen, Randi Ryan, Manik Aggarwal et al.
2026-09-28 · DOI: 10.1097/lvt.0000000000001011Letter to the editor: Reconsidering the temporal dynamics of sarcopenia in MELD-based allocation bias—A clinical perspective
Ying Zheng, Minge Shen, Ji Zhu, Yicheng Zhu et al.
2026-09-28 · DOI: 10.1097/lvt.0000000000001004A multidisciplinary clinic model for alcohol use disorder after liver transplantation: Implementation and early outcomes of the LIFT Clinic
Wei Zhang, Brooke Rice, Ana Ivkovic, Rachael Mahle et al.
2026-09-24 · DOI: 10.1097/lvt.0000000000001003Portal vein thrombosis increases short-term mortality among hospitalized patients with cirrhosis in a global cohort
Ashok Choudhury, Scott Silvey, Florence Wong, Patrick S. Kamath et al.
2026-09-21 · DOI: 10.1097/lvt.0000000000000994MELD-based allocation disproportionately prioritizes alcohol-associated hepatitis for liver transplant
Claire Durkin, Ravy Vajravelu, Shari Rogal, Therese Bittermann et al.
2026-09-21 · DOI: 10.1097/lvt.0000000000001000Cirrhotic cardiomyopathy is independently associated with peritransplant acute kidney injury in biliary atresia: A hepato-cardio-renal link
Divya G. Sabapathy, Auda P. Gonzalez, Christin Silos, Sanjiv Harpavat et al.
2026-09-18 · DOI: 10.1097/lvt.0000000000000989Beyond graft survival: Health literacy is associated with patient-reported health after liver transplantation
Dominic Denk, Lucia Alcober-Boquet, Alexander Queck
2026-09-18 · DOI: 10.1097/lvt.0000000000001001Pre-transplant cardiac evaluation in liver transplant recipients
Michael P. Dybala, Jacob K. Sterling, Lisa B. VanWagner, Daniel R. Schimmel et al.
2026-10 · DOI: 10.1097/lvt.0000000000000922Total intravenous versus volatile anesthesia in living donor hepatectomy: A global prospective cohort study from the international LDLT registry
Toby Lewis, Dimitri A. Raptis, Ilya Kantsedikas, Enrico Prosperi et al.
2026-09-18 · DOI: 10.1097/lvt.0000000000000981Reviews
Community Reviews
Version History
October 9, 2026 at 7:59 pm
September 25, 2026